Test Price
2,800 AED✅ Home Collection Available
KIF1A Gene SPG30 Genetic Test in UAE | 2800 AED | Comprehensive NGS Sequencing
Executive Summary & Core Metrics
This advanced genetic test provides precise diagnosis of KIF1A gene mutations causing hereditary spastic paraplegia type 30 (SPG30) with >99.9% accuracy. The Next‑Generation Sequencing (NGS) methodology covers the entire coding region and adjacent intronic sequences.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑accredited NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary telephonic post‑test guidance with a senior genetic counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The KIF1A gene SPG30 NGS test sequences the entire coding region of the KIF1A gene to identify pathogenic variants responsible for autosomal dominant hereditary spastic paraplegia type 30. This NGS‑based assay provides superior coverage compared to single‑variant tests, detecting single nucleotide variants, indels, and copy number changes with >99.9% accuracy.
| Feature | Our KIF1A NGS Test | Standard Genetic Panel |
|---|---|---|
| Methodology | Full‑gene Next Generation Sequencing (NGS) with copy number analysis | Targeted mutation genotyping or limited Sanger sequencing |
| Diagnostic Sensitivity | >99.9% for clinically relevant variants | Variable, often <70% for novel mutations |
| Turnaround Time | 3–4 Weeks | 2–6 Weeks (often without full bioinformatics) |
| Price | 2800 AED | 1900–3200 AED |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA: 9294403) advises: “This NGS test delivers high‑resolution genetic data that must be interpreted alongside a complete neurological examination and family history. A confirmed KIF1A mutation can guide prognosis and family planning, but it is not a substitute for ongoing specialised care. I encourage each patient to discuss their results with a clinical geneticist to fully understand the implications.”
Advisory: Medication and Treatment Continuity
⚠️ Important Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Genetic test results do not justify abrupt changes in therapy.
Exclusion Criteria & Safety Information
- Not suitable for individuals with active systemic infection or recent blood transfusion (within 4 weeks) without physician clearance.
- Testing of minors requires a DHA‑approved genetic counselling session and parental consent in compliance with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- Emergency Red Flags: Sudden loss of ambulation, acute vision changes, status epilepticus, or severe respiratory distress require immediate ER evaluation; the genetic test result does not replace emergency care.
- This test is not a standalone diagnostic tool; it should be ordered and interpreted by a Neurologist, Clinical Geneticist, or Genetic Counsellor.
Patient FAQ & Clinical Guidance
1. What exactly does the KIF1A gene SPG30 test analyse?
The KIF1A gene SPG30 test sequences your entire KIF1A gene to detect mutations causing hereditary spastic paraplegia type 30. This NGS assay reads every exon and flanking intronic regions, identifying single nucleotide variants, indels, and copy number changes with >99.9% accuracy. It is the most comprehensive molecular diagnostic tool for SPG30.
2. How accurate is this genetic test compared to older methods?
With Next‑Generation Sequencing (NGS), diagnostic sensitivity exceeds 99.9% for pathogenic variants, ensuring reliable genetic diagnosis. Unlike targeted genotyping, NGS uncovers both common and novel mutations, reducing false‑negative rates to less than 0.1%. Our ISO 9001:2015 certified lab uses validated bioinformatics pipelines.
3. How long will I wait for the result and what is included?
Turnaround time is 3 to 4 weeks from sample receipt, including comprehensive bioinformatics analysis and clinical interpretation. Your report will be signed by a board‑certified geneticist and includes variant classification (ACMG guidelines), clinical correlation, and a complimentary tele‑consultation with a genetic counsellor.
4. Is home sample collection available for this test?
Yes, for whole blood specimens, we provide VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection from 8 AM to 11 PM daily. Our trained phlebotomists follow strict safety and privacy protocols.
UAE Regulatory & Data Privacy Adherence
Compliance with UAE Data Protection Laws: All genetic data is handled in strict accordance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient consent and data security are prioritized at every step. Our laboratory operates under ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) and DHA license 1143.
Clinical & Logistical Metadata
| Test Name | KIF1A Gene SPG30 Genetic Test (NGS) |
| Price (AED) | 2800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (Peripheral). VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection available daily 8 AM – 11 PM. |
| Methodology Used | Next Generation Sequencing (NGS) – Full gene coding region and flanking introns, including copy number analysis. |
| ICD-10-CM Code | G11.4 |
| LOINC Code | 21634-2 |
| DHA Facility License & Laboratory Address | DHA License No: 1143. Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Corporate Lab Branding: DNA Labs UAE. |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians